在癌症中抗氧化剂的抗性机制
Michela Corsini1, Mattia Domenichini1, Elisa Moreschi1
1Department of Molecular and Translational Medicine, Via Branze 39, 25123 Brescia, University of Brescia, Italy; Mechanobiology Center, 25123 Brescia, University of Brescia, Italy.
Biochimica et biophysica acta. Reviews on cancer
|November 20, 2025
概括
癌细胞通过机械转导抵抗阿诺基斯,这是转移的一个关键步骤. 了解这些物理力量和细胞生存途径为癌症治疗提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物物理学的生物物理.
背景情况:
- 转移性癌细胞表现出对anoikis的抵抗力,这是脱离和传播的关键过程.
- 机械转导在癌细胞生存和适应机械应力方面发挥着至关重要的作用.
研究的目的:
- 审查癌症中抗氧化物耐药性的分子和生物物理机制.
- 探索机械传导在实现转移能力方面的作用.
主要方法:
- 关于参与阿诺基斯抗性的分子信号通路的文献综述.
- 生物物理力量的分析,包括机械传导,整蛋白信号传递和actomyosin收缩性.
- 检查可溶性介质如虹膜素及其在生存信号中的作用.
主要成果:
- 集成蛋白信号传递,YAP/TAZ通路,机械敏感离子通道,以及actomyosin收缩性是机械应激下生存的关键.
- 肌基因伊里辛作为一种机械模仿剂,激活生存途径.
- 机械异质性影响瘤中的特定环境适应策略.
结论:
- 机械传导是癌细胞转移能力的基本驱动因素.
- 准机械转导通路是干预转移性癌症的一个有希望的治疗策略.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K


